<?xml version="1.0" encoding="UTF-8"?>
<ref id="R22">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Rajdev</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chiao</surname>
    <given-names>EY</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lensing</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Amc 095 (AIDS malignancy Consortium): a phase I study of ipilimumab (IPI) and nivolumab (NIVO) in advanced HIV associated solid tumors (ST) with expansion cohorts in HIV associated solid tumors and classical Hodgkin lymphoma (cHL)</article-title>. 
  <source>JCO</source>
  <year>2018</year>;
  <volume>36</volume>:
  <elocation-id>TPS2597-TPS</elocation-id>:
  <fpage>TPS2597</fpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2018.36.15_suppl.TPS2597</pub-id>
 </mixed-citation>
</ref>
